header-image

Stability Studies to Support Shipping/Distribution of Pharmaceuticals and Biopharmaceuticals - Online Training Recording

Seminar-Nr. 22613

Referent:innen

Dr. Raphael Bar

Dr. Raphael Bar

BR Consulting

Dr. Thomas Fürst

Dr. Thomas Fürst

Boehringer Ingelheim

Zielsetzung

This Live Online Training will give an overview of tools that a Qualified Person (QP), Quality Assurance personnel or a Product Manager/Manufacturer should have in order to evaluate the impact of excursions from the storage label instructions on the disposition of distributed shipments of pharmaceutical/biopharmaceutical products.

Hintergrund

The formal stability studies of pharmaceuticals and biopharmaceuticals are a well-established discipline and they are regularly conducted at precisely monitored conditions of temperature (within 2 °C) and of humidity (within 5% RH) under cGMP. However, the inevitable processes of shipping and distributing medicines from the manufacturer to wholesaler to warehouses to the end user via air, ship or car exposes often the shipments to temperatures and humidity different from the label storage conditions. For instance, how would you handle a shipment that was exposed to a varying temperature up to 61oC in the airport for an accumulated duration of several days? How would you evaluate the quality of a refrigerated injectable that was exposed to near zero or freezing temperatures for a few hours? Would you release or reject such a shipment which may cost hundreds of thousands of dollars?

Shipping/distribution of a medicine is considered a “mobile storage”. However, a temperature excursion outside the label instructions may also be considered a ‘trauma” inflicted on the medicine and this may impact the quality of the newly arrived shipments. But, the big question remains: how would that ‘trauma” affect the quality at the end of the declared shelf life of any pharmaceutical and of a biopharmaceutical in particular? Will the long-term impact lead to a “hidden OOS”? This training will address these aspects. In addition, the course also includes two case studies and a session with video presentations. Further, a set of Q&A sessions will follow the lectures. Thus, take advantage of this opportunity to pose your questions.

Zielgruppe

This Live Online Training will be of significant value to
  •  Qualified Persons
  •  Quality Assurance personnel
  •  Pharmacists
  •  Project coordinators/product managers
  •  Stability testing personnel
  •  Stability program logistics personnel
  •  R&D personnel involved in product development

Date & Technical Requirements

To participate in an on demand training course or webinar, you do not need any software. The recordings are made available via a streaming server. In general, the recording is provided in MP4 format, which any PC (Microsoft Windows, Apple IOS) or tablet can easily display.

Timing and Duration:
When you register for the on demand Training course or webinar you can decide at what date you want to follow the training course online. For a 1-day training course you will have 2 days in which the stream is available (for 2-day training course 3 days and for a 3-day training course 4 days). Within in this timeframe you can start & stop the stream according to your needs.

In time before the scheduled date (your desired date) you will receive an e-mail from us with a link for direct participation as well as your log-in data.

Please be aware: The recording does not include the Q & A sessions.

Training Course Documentation and Certificate:
The presentation will be made available as PDF-files via download during the online training course. After the successful completion of the online training, you are able to download the certificate of attendance.

Programm

Overview of Stability Programs and Storage Statements
  • Stability studies and development phases
  • Long-term and accelerated storage conditions of new drug substances and products (EU, USA)
  • Stability storage programs for generic drugs (EU, USA)
  • Specific storage statements (EU, WHO, USP)
  • Labelling statements for various pharmaceuticals
Mean Kinetic Temperature (MKT) and World Climatic Zones/Uses and Misuses of MKT
  • Mean Kinetic Temperature (MKT) and relative humidity
  • Interpretation of MKT
  • MKT from temperature loggers
Stress Studies of Pharmaceuticals
  • Degradation reactions
  • Stressing factors and conditions
  • Stress studies in the pharmaceutical industry
Stability Studies to Support Shipping/Distribution of Pharmaceuticals and Biopharmaceuticals
  • Stress testing vs Forced Degradations
  • Studies at elevated extreme temperatures
  • Studies at low extreme conditions
  • When, how and what?
  • Thermal Cyclic studies
  • What attributes to test
Cycling Studies: Case Study

Excursions during Shipping and Distributions
  • “Time-out-of-Storage” and stability budget“ Concept
  • Handling an excursion
Investigating Excursions during Shipping and Distributions
  • What stability data are required to investigate temperature excursions
  • Responsibilities of manufacturer, distributor and QP
Video Presentations

Evaluation of the Impact of Temperature Excursions
  • Estimation of the impact by the excursion temperature on the quality Attribute
  • Estimation of the quality attribute at the end of shelflife/retest date
Handling of Excursions: Case Studies
 
Recording from 10/11 September 2025
Duration of the recording: approx. 7 h 30 min

ECA-Member*: € 1890,-
Regular Fee*: € 2090,-
EU/GMP Inspectorates*: € 1045,-
APIC Member Discount*: € 1990,-

Alle Preise zzgl. MwSt. Wichtige Hinweise zur Umsatzsteuer.

* auch unkompliziert per Kreditkarte bezahlbar
American Express Visa Mastercard

icon
Weitere Termine vor Ort
Weitere Termine vor Ort nicht verfügbar
icon
Weitere Termine online
Weitere Termine online nicht verfügbar

Haben Sie noch Fragen?

Wir stehen Ihnen für weitere Auskünfte gerne zur Verfügung.
Tel.: +49 6221 84 44 0
E-Mail: info@concept-heidelberg.de

Frau mit Headset

Zurück

Teilnehmerstimmen - das sagen andere über unsere Seminare:

„Flüssiger Vortrag, neue Aspekte wurden kommuniziert.“
Rainer Tryankowski, DRK-Blutspendedienst  Rheinland-Pfalz und Saarland
Webinar GDP Update 2025
März 2025

„Sehr guter Überblick über die aktuellen GDP Themen. Sehr kurzweilig.“
Juliana Dodillet, Pharma Resources GmbH
Webinar GDP Update 2025
März 2025

„Sehr ausführliche Erklärung“
Jacqueline Buckel, UNITAX-Pharmalogistik GmbH
Webinar GDP Update 2025
März 2025

„Sehr gut: praxisorientiert; Präsentation logisch nachvollziehbar“
Gabriele Unger, Astro-Pharma GmbH
Webinar GDP Update 2025
März 2025

„Sehr informativ und umfangreich, aber immer auf den Punkt gebracht“
Jasmine Merz, Peppler GmbH
Webinar GDP Update 2025
März 2025